References
This list refers to the citations made over the various pages in the 'CONSORT Statement' section of the website, which replicate the published CONSORT 2001 Explanatory document. For more references, please visit the CONSORT Database.
| 1 | Cochrane AL. Effectiveness and efficiency; random reflections on health services. Abingdon, Berkshire, UK: The Nuffield Provincial Hospitals Trust; 1972:2. |
| 2 | Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA. 1995;273:408-12. [PMID: 0007823387] |
| 3 | Moher D. CONSORT: an evolving tool to help improve the quality of reports of randomized controlled trials. Consolidated Standards of Reporting Trials. JAMA. 1998;279:1489-91. [PMID: 0009600488] |
| 4 | Kjaergård LL, Villumsen J, Gluud C. Quality of randomised clinical trials affects estimates of intervention efficacy. 1999. Rome, Italy, 7th Cochrane Colloquium. 1999. |
| 5 | Jüni P, Altman DG, Egger M. Assessing the quality of controlled clinical trials. BMJ. 2001;323:42-46. [PMID: 0011440947] |
| 6 | Veldhuyzen vZS, Cleary C, Talley NJ, et al. Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for design of future trials. Am J Gastroenterol. 1996;91:660-73. [PMID: 0008677926] |
| 7 | Talley NJ, Owen BK, Boyce P, Paterson K. Psychological treatments for irritable bowel syndrome: a critique of controlled treatment trials. Am J Gastroenterol. 1996;91:277-83. [PMID: 0008607493] |
| 8 | Adetugbo K, Williams H. How well are randomized controlled trials reported in the dermatology literature? Arch Dermatol. 2000;136:381-5. [PMID: 0010724201] |
| 9 | Kjaergård LL, Nikolova D, Gluud C. Randomized clinical trials in HEPATOLOGY: predictors of quality. Hepatology. 1999;30:1134-8. [PMID: 10534332] |
| 10 | Schor S, Karten I. Statistical evaluation of medical journal manuscripts. JAMA. 1966;195:1123-8. [PMID: 0005952081] |
| 11 | Gore SM, Jones IG, Rytter EC. Misuse of statistical methods: critical assessment of articles in BMJ from January to March 1976. Br Med J. 1977;1:85-7. [PMID: 0000832023] |
| 12 | Hall JC, Hill D, Watts JM. Misuse of statistical methods in the Australasian surgical literature. Aust N Z J Surg. 1982;52:541-3. [PMID: 0006959608] |
| 13 | Altman DG. Statistics in medical journals. Stat Med. 1982;1:59-71. [PMID: 0007187083] |
| 14 | Pocock SJ, Hughes MD, Lee RJ. Statistical problems in the reporting of clinical trials. A survey of three medical journals. N Engl J Med. 1987;317:426-32. [PMID: 0003614286] |
| 15 | Altman DG. The scandal of poor medical research. BMJ. 1994;308:283-4. [PMID: 0008124111] |
| 16 | DerSimonian R, Charette LJ, McPeek B, Mosteller F. Reporting on methods in clinical trials. N Engl J Med. 1982;306:1332-7. [PMID: 0007070458] |
| 17 | Moher D, Dulberg CS, Wells GA. Statistical power, sample size, and their reporting in randomized controlled trials. JAMA. 1994;272:122-4. [PMID: 0008015121] |
| 18 | Hollis S, Campbell F. What is meant by intention to treat analysis? Survey of published randomised controlled trials. BMJ. 1999;319:670-4. [PMID: 0010480822] |
| 19 | Nicolucci A, Grilli R, Alexanian AA, Apolone G, Torri V, Liberati A. Quality, evolution, and clinical implications of randomized, controlled trials on the treatment of lung cancer. A lost opportunity for meta-analysis. JAMA. 1989;262:2101-7. [PMID: 0002677423] |
| 20 | Sonis J, Joines J. The quality of clinical trials published in The Journal of Family Practice, 1974-1991. J Fam Pract. 1994;39:225-35. [PMID: 0008077901] |
| 21 | Schulz KF, Chalmers I, Grimes DA, Altman DG. Assessing the quality of randomization from reports of controlled trials published in obstetrics and gynecology journals. JAMA. 1994;272:125-8. [PMID: 0008015122] |
| 22 | Schulz KF. Randomised trials, human nature, and reporting guidelines. Lancet. 1996;348:596-8. [PMID: 0008774577] |
| 23 | Ah-See KW, Molony NC. A qualitative assessment of randomized controlled trials in otolaryngology. J Laryngol Otol. 1998;112:460-3. [PMID: 0009747475] |
| 24 | Bath FJ, Owen VE, Bath PM. Quality of full and final publications reporting acute stroke trials: a systematic review. Stroke. 1998;29:2203-10. [PMID: 0009756604] |
| 25 | Altman DG, Doré CJ. Randomisation and baseline comparisons in clinical trials. Lancet. 1990;335:149-53. [PMID: 0001967441] |
| 26 | Williams DH, Davis CE. Reporting of assignment methods in clinical trials. Control Clin Trials. 1994;15:294-8. [PMID: 0007956269] |
| 27 | Mosteller F, Gilbert JP, McPeek B. Reporting standards and research strategies for controlled trials. Agenda for the editor. Control Clin Trials. 1980;1:37-58. |
| 28 | Gøtzsche PC. Methodology and overt and hidden bias in reports of 196 double-blind trials of nonsteroidal antiinflammatory drugs in rheumatoid arthritis. Control Clin Trials. 1989;10:31-56. [PMID: 0002702836] |
| 29 | Tyson JE, Furzan JA, Reisch JS, Mize SG. An evaluation of the quality of therapeutic studies in perinatal medicine. J Pediatr. 1983;102:10-3. [PMID: 0006848706] |
| 30 | Moher D, Fortin P, Jadad AR, et al. Completeness of reporting of trials published in languages other than English: implications for conduct and reporting of systematic reviews. Lancet. 1996;347:363-6. [PMID: 0008598702] |
| 31 | Junker CA. Adherence to published standards of reporting: a comparison of placebo-controlled trials published in English or German. JAMA. 1998;280:247-9. [PMID: 0009676671] |
| 32 | Altman DG. Randomisation. BMJ. 1991;302:1481-2. [PMID: 0001855013] |
| 33 | Anonymous. Streptomycin treatment of pulmonary tuberculosis: a Medical Research Council investigation. BMJ. 1948;2:769-82. |
| 34 | Schulz KF. Randomized controlled trials. Clin Obstet Gynecol. 1998;41:245-56. [PMID: 0009646957] |
| 35 | Armitage P. The role of randomization in clinical trials. Stat Med. 1982;1:345-52. [PMID: 0007187102] |
| 36 | Greenland S. Randomization, statistics, and causal inference. Epidemiology. 1990;1:421-9. [PMID: 0002090279] |
| 37 | Kleijnen J, Gøtzsche P, Kunz RA, Oxman AD, Chalmers I. So what's so special about randomisation. In: Maynard A, Chalmers I, eds. Non-random reflections on health services research. London: BMJ Books; 1997:93-106. |
| 38 | Chalmers I. Assembling comparison groups to assess the effects of health care. J R Soc Med. 1997;90:379-86. [PMID: 0009290419] |
| 39 | Thornley B, Adams C. Content and quality of 2000 controlled trials in schizophrenia over 50 years. BMJ. 1998;317:1181-4. [PMID: 0009794850] |
| 40 | The Standards of Reporting Trials Group. A proposal for structured reporting of randomized controlled trials. The Standards of Reporting Trials Group. JAMA. 1994;272:1926-31. [PMID: 0007990245] |
| 41 | Working Group on Recommendations for Reporting of Clinical Trials in the Biomedical Literature. Call for comments on a proposal to improve reporting of clinical trials in the biomedical literature. Working Group on Recommendations for Reporting of Clinical Trials in the Biomedical Literature. Ann Intern Med. 1994;121:894-5. [PMID: 0007978706] |
| 42 | Rennie D. Reporting randomized controlled trials. An experiment and a call for responses from readers. JAMA. 1995;273:1054-5. [PMID: 0007897791] |
| 43 | Begg C, Cho M, Eastwood S, et al. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA. 1996;276:637-9. [PMID: 0008773637] |
| 44 | Siegel JE, Weinstein MC, Russell LB, Gold MR. Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine. JAMA. 1996;276:1339-41. [PMID: 0008861994] |
| 45 | Drummond MF, Jefferson TO. Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party. BMJ. 1996;313:275-83. [PMID: 0008704542] |
| 46 | Lang TA, Secic M. How to report statistics in medicine. Annotated guidelines for authors, editors, and reviewers. Philadelphia: American College of Physicians; 1997. |
| 47 | Staquet M, Berzon R, Osoba D, Machin D. Guidelines for reporting results of quality of life assessments in clinical trials. Qual Life Res. 1996;5:496-502. [PMID: 0008973129] |
| 48 | Altman DG. Better reporting of randomised controlled trials: the CONSORT statement. BMJ. 1996;313:570-1. [PMID: 0008806240] |
| 49 | Anonymous. [A standard method for reporting ramdomized medical scientific research; the 'Consolidation of the standards of reporting trials' (CONSORT)] Verslaglegging van gerandomiseerd medisch-wetenschappelijk onderzoek volgens een standaardmethode; de 'Consolidation of the standards of reporting trials' (CONSORT). Ned Tijdschr Geneeskd. 1998;142:1089-91. [PMID: 0009623225] |
| 50 | Huston P, Hoey J. CMAJ endorses the CONSORT statement. CONsolidation of Standards for Reporting Trials. CMAJ. 1996;155:1277-82. [PMID: 0008911294] |
| 51 | Ausejo M, Saenz A, Moher D. [CONSORT: an attempt to improve the quality of publication of clinical trials] CONSORT: un intento de mejorar la calidad de la publicacion de ensayos clinicos. EDAT- 1998/06/20 02:16 MHDA- 1998/06/20 02:16. Aten Primaria. 1998;21:351-2. [PMID: 0009633133] |
| 52 | Davidoff F. News from the International Committee of Medical Journal Editors. Ann Intern Med. 2000;133:229-31. [PMID: 0010906840] |
| 53 | Moher D, Jones A, Lepage L. Use of the CONSORT statement and quality of reports of randomized trials: a comparative before-and-after evaluation. JAMA. 2001;285:1992-5. [PMID: 11308436] |
| 54 | Egger M, Jüni P, Bartlett C, for the CONSORT Group. The value of flow diagrams in reports of randomized controlled trials: bibliographic study. JAMA. 2001;285:1996-9. [PMID: 11308437] |
| 55 | Meinert CL. Beyond CONSORT: need for improved reporting standards for clinical trials. Consolidated Standards of Reporting Trials. JAMA. 1998;279:1487-9. [PMID: 0009600487] |
| 56 | Moher D, Schulz KF, Altman DG, for the CONSORT Group. The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials. Ann Intern Med. 2001;134:657-62. [PMID: 11304106] |
| 57 | Moher D, Schulz KF, Altman DG, for the CONSORT Group. The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials. JAMA. 2001;285:1987-91. [PMID: 11308435] |
| 58 | Moher D, Schulz KF, Altman DG, for the CONSORT Group. The CONSORT statement: revised recommendations for improving the quality of reports parallel group randomized trials. Lancet. 2001;357:1191-94. [PMID: 11323066] |
| 59 | Pocock SJ. Clinical trials: a practical approach. Chichester, UK: John Wiley; 1983. |
| 60 | Meinert CL. Clinical trials: design, conduct and analysis. New York: Oxford University Press; 1986. |
| 61 | Friedman LM, Furberg CD, DeMets DL. Fundamentals of clinical trials. 3rd ed. New York: Springer; 1998. |
| 62 | Bolliger CT, Zellweger JP, Danielsson T, et al. Smoking reduction with oral nicotine inhalers: double blind, randomised clinical trial of efficacy and safety. BMJ. 2000;321:329-33. [PMID: 0010926587] |
| 63 | Prasad AS, Fitzgerald JT, Bao B, Beck FW, Chandrasekar PH. Duration of symptoms and plasma cytokine levels in patients with the common cold treated with zinc acetate. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 2000;133:245-52. [PMID: 0010929163] |
| 64 | Dickersin K, Scherer R, Lefebvre C. Identifying relevant studies for systematic reviews. BMJ. 1994;309:1286-91. [PMID: 0007718048] |
| 65 | Lefebvre C, Clarke M. Identifying randomised trials. In: Egger M, Smith GD, Altman DG, eds. Systematic reviews in health care: meta-analysis in context. London: BMJ Books: 2001:69-86. |
| 66 | Haynes RB, Mulrow CD, Huth EJ, Altman DG, Gardner MJ. More informative abstracts revisited. Ann Intern Med. 1990;113:69-76. [PMID: 0002190518] |
| 67 | Taddio A, Pain T, Fassos FF, Boon H, Ilersich AL, Einarson TR. Quality of nonstructured and structured abstracts of original research articles in the British Medical Journal, the Canadian Medical Association Journal and the Journal of the American Medical Association. CMAJ. 1994;150:1611-5. [PMID: 0008174031] |
| 68 | Hartley J, Sydes M, Blurton A. Obtaining information accurately and quickly: Are structured abstracts more efficient? J Inform Sci. 1996;22:349-56. |
| 69 | Dammers JW, Veering MM, Vermeulen M. Injection with methylprednisolone proximal to the carpal tunnel: randomised double blind trial. BMJ. 1999;319:884-6. [PMID: 0010506042] |
| 70 | Sandler AD, Sutton KA, DeWeese J, Girardi MA, Sheppard V, Bodfish JW. Lack of benefit of a single dose of synthetic human secretin in the treatment of autism and pervasive developmental disorder. N Engl J Med. 1999;341:1801-6. [PMID: 0010588965] |
| 71 | World Medical Association. Declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. JAMA. 1997;277:925-6. [PMID: 0009062334] |
| 72 | Lau J, Antman EM, Jimenez-Silva J, Kupelnick B, Mosteller F, Chalmers TC. Cumulative meta-analysis of therapeutic trials for myocardial infarction. N Engl J Med. 1992;327:248-54. [PMID: 0001614465] |
| 73 | Savulescu J, Chalmers I, Blunt J. Are research ethics committees behaving unethically? Some suggestions for improving performance and accountability. BMJ. 1996;313:1390-3. [PMID: 0008956711] |
| 74 | Sinei SK, Schulz KF, Lamptey PR, et al. Preventing IUCD-related pelvic infection: the efficacy of prophylactic doxycycline at insertion. Br J Obstet Gynaecol. 1990;97:412-9. [PMID: 0002196934] |
| 75 | Rodgers A, MacMahon S. Systematic underestimation of treatment effects as a result of diagnostic test inaccuracy: implications for the interpretation and design of thromboprophylaxis trials. Thromb Haemost. 1995;73:167-71. [PMID: 0007792725] |
| 76 | Fuks A, Weijer C, Freedman B, Shapiro S, Skrutkowska M, Riaz A. A study in contrasts: eligibility criteria in a twenty-year sample of NSABP and POG clinical trials. National Surgical Adjuvant Breast and Bowel Program. Pediatric Oncology Group. J Clin Epidemiol. 1998;51:69-79. [PMID: 0009474067] |
| 77 | Hall JC, Mills B, Nguyen H, Hall JL. Methodologic standards in surgical trials. Surgery. 1996;119:466-72. [PMID: 0008644014] |
| 78 | Shapiro SH, Weijer C, Freedman B. Reporting the study populations of clinical trials. Clear transmission or static on the line? J Clin Epidemiol. 2000;53:973-9. [PMID: 0011027928] |
| 79 | Taylor MA, Reilly D, Llewellyn-Jones RH, McSharry C, Aitchison TC. Randomised controlled trial of homoeopathy versus placebo in perennial allergic rhinitis with overview of four trial series. BMJ. 2000;321:471-6. [PMID: 0010948025] |
| 80 | Mease PJ, Goffe BS, Metz J, VanderStoep A, Finck B, Burge DJ. Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial. Lancet. 2000;356:385-90. [PMID: 0010972371] |
| 81 | Roberts C. The implications of variation in outcome between health professionals for the design and analysis of randomized controlled trials. Stat Med. 1999;18:2605-15. [PMID: 0010495459] |
| 82 | Sadler LC, Davison T, McCowan LM. A randomised controlled trial and meta-analysis of active management of labour. BJOG. 2000;107:909-15. [PMID: 0010901564] |
| 83 | McDowell I, Newell C. Measuring health: a guide to rating scales and questionnaires. 2nd ed. New York: University Press; 1996. |
| 84 | Streiner D, Normand C. Health measurement scales: a practical guide to their development and use. 2nd ed. Oxford: Oxford University Press; 1995. |
| 85 | Sanders C, Egger M, Donovan J, Tallon D, Frankel S. Reporting on quality of life in randomised controlled trials: bibliographic study. BMJ. 1998;317:1191-4. [PMID: 0009794853] |
| 86 | Marshall M, Lockwood A, Bradley C, Adams C, Joy C, Fenton M. Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia. Br J Psychiatry. 2000;176:249-52. [PMID: 0010755072] |
| 87 | Jadad AR, Boyle M, Cunningham C, Kim M, Schachar R. Treatment of Attention-Deficit/Hyperactivity Disorder. Evidence Report/Technology Assessment No. 11. Rockville, MD: U.S. Department of Health and Human Services, Public Health Service, Agency for Healthcare Research and Quality; 1999. AHQR publication no. 00-E005. |
| 88 | Schachter HM, Pham B, King J, Langford S, Moher D. The efficacy and safety of methylphenidate in attention deficit disorder: A systematic review and meta-analyis. Prepared for the Therapeutics Inititiative, Vancouver, B.C., and the British Columbia Ministry for Children and Families. 2000. |
| 89 | Kahn JO, Cherng DW, Mayer K, Murray H, Lagakos S. Evaluation of HIV-1 immunogen, an immunologic modifier, administered to patients infected with HIV having 300 to 549 x 106/L CD4 cell counts: A randomized controlled trial. JAMA. 2000;284:2193-202. [PMID: 0011056590] |
| 90 | UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998;317:703-13. [PMID: 0009732337] |
| 91 | Heit JA, Elliott CG, Trowbridge AA, Morrey BF, Gent M, Hirsh J. Ardeparin sodium for extended out-of-hospital prophylaxis against venous thromboembolism after total hip or knee replacement. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 2000;132:853-61. [PMID: 0010836911] |
| 92 | Morrell CJ, Spiby H, Stewart P, Walters S, Morgan A. Costs and effectiveness of community postnatal support workers: randomised controlled trial. BMJ. 2000;321:593-8. [PMID: 0010977833] |
| 93 | Campbell MJ, Julious SA, Altman DG. Estimating sample sizes for binary, ordered categorical, and continuous outcomes in two group comparisons. BMJ. 1995;311:1145-8. [PMID: 0007580713] |
| 94 | Altman DG, Bland JM. Absence of evidence is not evidence of absence. BMJ. 1995;311:485 [PMID: 0007647644] |
| 95 | Freiman JA, Chalmers TC, Smith HJ, Kuebler RR. The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 "negative" trials. N Engl J Med. 1978;299:690-4. [PMID: 0000355881] |
| 96 | Yusuf S, Collins R, Peto R. Why do we need some large, simple randomized trials? Stat Med. 1984;3:409-22. [PMID: 0006528136] |
| 97 | Goodman SN, Berlin JA. The use of predicted confidence intervals when planning experiments and the misuse of power when interpreting results. Ann Intern Med. 1994;121:200-6. [PMID: 0008017747] |
| 98 | MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet. 1991;338:131-7. [PMID: 0001677062] |
| 99 | Galgiani JN, Catanzaro A, Cloud GA, et al. Comparison of Oral Fluconazole and Itraconazole for Progressive, Nonmeningeal Coccidioidomycosis. A Randomized, Double-Blind Trial. Ann Intern Med. 2000;133:676-86. [PMID: 0011074900] |
| 100 | Geller NL, Pocock SJ. Interim analyses in randomized clinical trials: ramifications and guidelines for practitioners. Biometrics. 1987;43:213-23. [PMID: 0003567306] |
| 101 | Berry DA. Interim analyses in clinical trials: classical vs. Bayesian approaches. Stat Med. 1985;4:521-6. [PMID: 0004089353] |
| 102 | Pocock SJ. When to stop a clinical trial. BMJ. 1992;305:235-40. [PMID: 0001392832] |
| 103 | DeMets DL, Pocock SJ, Julian DG. The agonising negative trend in monitoring of clinical trials. Lancet. 1999;354:1983-8. [PMID: 0010622312] |
| 104 | Buyse M. Interim analyses, stopping rules and data monitoring in clinical trials in Europe. Stat Med. 1993;12:509-20. [PMID: 0008493429] |
| 105 | Altman DG, Bland JM. How to randomise. BMJ. 1999;319:703-4. [PMID: 0010480833] |
| 106 | Schulz KF. Subverting randomization in controlled trials. JAMA. 1995;274:1456-8. [PMID: 0007474192] |
| 107 | Enas GG, Enas NH, Spradlin CT, Wilson MG, Wiltse CG. Baseline comparability in clinical trials. Drug Inf J. 1990;24:541-8. |
| 108 | Treasure T, MacRae KD. Minimisation: the platinum standard for trials?. Randomisation doesn't guarantee similarity of groups; minimisation does. BMJ. 1998;317:362-3. [PMID: 0009694748] |
| 109 | Kernan WN, Viscoli CM, Makuch RW, Brass LM, Horwitz RI. Stratified randomization for clinical trials. J Clin Epidemiol. 1999;52:19-26. [PMID: 0009973070] |
| 110 | Tu D, Shalay K, Pater J. Adjustment of treatment effect for covariates in clinical trials: statistical and regulatory issues. Drug Inf J. 2000;34:511-23. |
| 111 | Chappell LC, Seed PT, Briley AL, et al. Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial. Lancet. 1999;354:810-6. [PMID: 0010485722] |
| 112 | Chalmers TC, Levin H, Sacks HS, Reitman D, Berrier J, Nagalingam R. Meta-analysis of clinical trials as a scientific discipline. I: Control of bias and comparison with large co-operative trials. Stat Med. 1987;6:315-28. [PMID: 0002887023] |
| 113 | Pocock SJ. Statistical aspects of clinical trial design. Statistician. 1982;31:1-18. |
| 114 | Haag U. Technologies for automating randomized treatment assignment in clinical trials. Drug Inf J. 1998;32:11 |
| 115 | LaCroix AZ, Ott SM, Ichikawa L, Scholes D, Barlow WE. Low-dose hydrochlorothiazide and preservation of bone mineral density in older adults. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 2000;133:516-26. [PMID: 0011015164] |
| 116 | Noseworthy JH, Ebers GC, Vandervoort MK, Farquhar RE, Yetisir E, Roberts R. The impact of blinding on the results of a randomized, placebo-controlled multiple sclerosis clinical trial. Neurology. 1994;44:16-20. [PMID: 0008290055] |
| 117 | Gøtzsche PC. Blinding during data analysis and writing of manuscripts. Control Clin Trials. 1996;17:285-90. [PMID: 0008889343] |
| 118 | Carley SD, Libetta C, Flavin B, Butler J, Tong N, Sammy I. An open prospective randomised trial to reduce the pain of blood glucose testing: ear versus thumb. BMJ. 2000;321:20 [PMID: 0010875827] |
| 119 | Day SJ, Altman DG. Statistics notes: blinding in clinical trials and other studies. BMJ. 2000;321:504 [PMID: 0010948038] |
| 120 | Devereaux PJ, Manns BJ, Ghali WA, Quan H, Lacchetti C, Guyatt GH. In the dark: physician interpretations and expert definitions of blinding in randomized controlled trials. JAMA. 2001;285:2000-3. [PMID: 11308438] |
| 121 | Schulz KF, Grimes DA, Altman DG, Hayes RJ. Blinding and exclusions after allocation in randomised controlled trials: survey of published parallel group trials in obstetrics and gynaecology. BMJ. 1996;312:742-4. [PMID: 0008605459] |
| 122 | Cheng K, Smyth RL, Motley J, O'Hea U, Ashby D. Randomized controlled trials in cystic fibrosis (1966-1997) categorized by time, design, and intervention. Pediatr Pulmonol. 2000;29:1-7. [PMID: 0010613779] |
| 123 | Lang T. Masking or Blinding? An unscientific survey of mostly medical journal editors on the great debate. Med Gen Med. 2000;E25 [PMID: 0011104471] |
| 124 | Lao L, Bergman S, Hamilton GR, Langenberg P, Berman B. Evaluation of acupuncture for pain control after oral surgery. Arch Otolaryngol Head Neck Surg. 1999;125:567-72. [PMID: 0010326816] |
| 125 | Quitkin FM, Rabkin JG, Gerald J, Davis JM, Klein DF. Validity of clinical trials of antidepressants. Am J Psychiatry. 2000;157:327-37. [PMID: 0010698806] |
| 126 | Nacul LC, Kirkwood BR, Arthur P, Morris SS, Magalhaes M, Fink MC. Randomised, double blind, placebo controlled clinical trial of efficacy of vitamin A treatment in non-measles childhood pneumonia. BMJ. 1997;315:505-10. [PMID: 0009329303] |
| 127 | Altman DG, Gore SM, Gardner MJ, Pocock SJ. Statistical guidelines for contributors to medical journals. In: Altman DG, Machin D, Bryant TN, Gardner MJ, eds. Statistics with confidence. 2nd ed. London: BJM Books; 2000:171-90. |
| 128 | Altman DG, Bland JM. Statistics notes. Units of analysis. BMJ. 1997;314:1874 [PMID: 0009224131] |
| 129 | Bolton S. Independence and statistical inference in clinical trial designs: a tutorial review. J Clin Pharmacol. 1998;38:408-12. [PMID: 0009602951] |
| 130 | Greenland S. Principles of multilevel modelling. Int J Epidemiol. 2000;29:158-67. [PMID: 0010750618] |
| 131 | Saunders M, Dische S, Barrett A, Harvey A, Gibson D, Parmar M. Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial. CHART Steering Committee. Lancet. 1997;350:161-5. [PMID: 0009250182] |
| 132 | Matthews JN, Altman DG. Interaction 3: How to examine heterogeneity. BMJ. 1996;313:862 [PMID: 0008870577] |
| 133 | Assmann SF, Pocock SJ, Enos LE, Kasten LE. Subgroup analysis and other (mis)uses of baseline data in clinical trials. Lancet. 2000;355:1064-9. [PMID: 0010744093] |
| 134 | Matthews JN, Altman DG. Statistics notes. Interaction 2: Compare effect sizes not P values. BMJ. 1996;313:808 [PMID: 0008842080] |
| 135 | Oxman AD, Guyatt GH. A consumer's guide to subgroup analyses. Ann Intern Med. 1992;116:78-84. [PMID: 0001530753] |
| 136 | Steyerberg EW, Bossuyt PM, Lee KL. Clinical trials in acute myocardial infarction: should we adjust for baseline characteristics? Am Heart. 2000;139:745-51. [PMID: 0010783203] |
| 137 | Altman DG. Adjustment for covariate imbalance. In: Armitage P, Colton T, eds. Encyclopedia of Biostatistics. Chichester: John Wiley; 1998:1000-5. |
| 138 | Concato J, Feinstein AR, Holford TR. The risk of determining risk with multivariable models. Ann Intern Med. 1993;118:201-10. [PMID: 0008417638] |
| 139 | Bender R, Grouven U. Logistic regression models used in medical research are poorly presented. BMJ. 1996;313:628 [PMID: 0008806274] |
| 140 | Khan KS, Chien PF, Dwarakanath LS. Logistic regression models in obstetrics and gynecology literature. Obstet Gynecol. 1999;93:1014-20. [PMID: 0010362173] |
| 141 | Sackett DL, Gent M. Controversy in counting and attributing events in clinical trials. N Engl J Med. 1979;301:1410-2. [PMID: 514321] |
| 142 | May GS, DeMets DL, Friedman LM, Furberg C, Passamani E. The randomized clinical trial: bias in analysis. Circulation. 1981;64:669-73. [PMID: 0007023743] |
| 143 | Altman DG, Cuzick J, Peto J. More on zidovudine in asymptomatic HIV infection. N Engl J Med. 1994;330:1758-9. [PMID: 0008190146] |
| 144 | Serruys PW, van Hout B, Bonnier H, et al. Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II). Lancet. 1998;352:673-81. [PMID: 0009728982] |
| 145 | Bove G, Nilsson N. Spinal manipulation in the treatment of episodic tension-type headache: a randomized controlled trial. JAMA. 1998;280:1576-9. [PMID: 0009820258] |
| 146 | Cunningham D, Pyrhonen S, James RD, et al. Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer. Lancet. 1998;352:1413-8. [PMID: 0009807987] |
| 147 | van Loon AJ, Mantingh A, Serlier EK, Kroon G, Mooyaart EL, Huisjes HJ. Randomised controlled trial of magnetic-resonance pelvimetry in breech presentation at term. Lancet. 1997;350:1799-804. [PMID: 0009428250] |
| 148 | Brown MJ, Palmer CR, Castaigne A, et al. Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT). Lancet. 2000;356:366-72. [PMID: 0010972368] |
| 149 | Shuster JJ. Median follow-up in clinical trials. J Clin Oncol. 1991;9:191-2. [PMID: 0001985169] |
| 150 | Altman DG, De Stavola BL, Love SB, Stepniewska KA. Review of survival analyses published in cancer journals. Br J Cancer. 1995;72:511-8. [PMID: 0007640241] |
| 151 | Senn S. Base logic: tests of baseline balance in randomized clinical trials. Clin Res Regulatory Affairs. 1995;12:171-82. |
| 152 | Haderslev KV, Tjellesen L, Sorensen HA, Staun M. Alendronate increases lumbar spine bone mineral density in patients with Crohn's disease. Gastroenterology. 2000;119:639-46. [PMID: 0010982756] |
| 153 | Fields WS, Maslenikov V, Meyer JS, Hass WK, Remington RD, Macdonald M. Joint study of extracranial arterial occlusion. V. Progress report of prognosis following surgery or nonsurgical treatment for transient cerebral ischemic attacks and cervical carotid artery lesions. JAMA. 1970;211:1993-2003. [PMID: 0005467158] |
| 154 | Lee YJ, Ellenberg JH, Hirtz DG, Nelson KB. Analysis of clinical trials by treatment actually received: is it really an option? Stat Med. 1991;10:1595-605. [PMID: 0001947515] |
| 155 | Lewis JA, Machin D. Intention to treat--who should use ITT? Br J Cancer. 1993;68:647-50. [PMID: 0008398686] |
| 156 | Lachin JL. Statistical considerations in the intent-to-treat principle. Control Clin Trials. 2000;21:526 [PMID: 0011018568] |
| 157 | Sheiner LB, Rubin DB. Intention-to-treat analysis and the goals of clinical trials. Clin Pharmacol Ther. 1995;57:6-15. [PMID: 0007828382] |
| 158 | Nagelkerke N, Fidler V, Bernsen R, Borgdorff M. Estimating treatment effects in randomized clinical trials in the presence of non-compliance. Stat Med. 2000;19:1849-64. [PMID: 0010867675] |
| 159 | Ruiz-Canela M, Martínez-González MA, de Irala-Estévez J. Intention to treat analysis is related to methodological quality. BMJ. 2000;320:1007-8. [PMID: 0010753165] |
| 160 | Altman DG. Confidence intervals in practice. In: Altman DG, Machin D, Bryant T, Gardner MJ, eds. Statistics with confidence. 2nd ed. London: BMJ Books; 2000:6-14. |
| 161 | Altman DG. Clinical trials and meta-analyses. In: Altman DG, Machin D, Bryant T, Gardner MJ, eds. Statistics with confidence. 2nd ed. London: BMJ Books; 2000:120-38. |
| 162 | International Committee of Medical Journal Editors. Uniform requirements for manuscripts submitted to biomedical journals. International Committee of Medical Journal Editors. Ann Intern Med. 1997;126:36-47. [PMID: 0008992922] |
| 163 | Gardner MJ, Altman DG. Confidence intervals rather than P values: estimation rather than hypothesis testing. Br Med J (Clin Res Ed). 1986;292:746-50. [PMID: 0003082422] |
| 164 | Bailar JC, Mosteller F. Guidelines for statistical reporting in articles for medical journals. Amplifications and explanations. Ann Intern Med. 1988;108:266-73. [PMID: 0003341656] |
| 165 | Hutton JL, Williamson PR. Bias in meta-analysis due to outcome variable selection within studies. Appl Stat. 2000;49:359-70. |
| 166 | Egger M, Dickersin K, Davey Smith G. Problems and limitations in conducting systematic reviews. In: Egger M, Davey Smith G, Altman DG, eds. Systematic Reviews in Health Care: Meta-Analysis in Context. London: BMJ Books; 2001:43-68. |
| 167 | Bland JM. Quoting intermediate analyses can only mislead. BMJ. 1997;314:1907-8. [PMID: 0009224157] |
| 168 | Cook RJ, Sackett DL. The number needed to treat: a clinically useful measure of treatment effect. BMJ. 1995;310:452-4. [PMID: 0007873954] |
| 169 | Altman DG, Andersen PK. Calculating the number needed to treat for trials where the outcome is time to an event. BMJ. 1999;319:1492-5. [PMID: 0010582940] |
| 170 | Tukey JW. Some thoughts on clinical trials, especially problems of multiplicity. Science. 1977;198:679-84. [PMID: 0000333584] |
| 171 | Yusuf S, Wittes J, Probstfield J, Tyroler HA. Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials. JAMA. 1991;266:93-8. [PMID: 0002046134] |
| 172 | Hahn S, Williamson PR, Hutton JL, Garner P, Flynn EV. Assessing the potential for bias in meta-analysis due to selective reporting of subgroup analyses within studies. Stat Med. 2000;19:3325-36. [PMID: 0011122498] |
| 173 | Levin M, Quint PA, Goldstein B, et al. Recombinant bactericidal/permeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: a randomised trial. rBPI21 Meningococcal Sepsis Study Group. Lancet. 2000;356:961-7. [PMID: 0011041396] |
| 174 | Ioannidis JP, Contopoulos-Ioannidis DG. Reporting of safety data from randomised trials. Lancet. 1998;352:1752-3. [PMID: 0011242428] |
| 175 | Horton R. The rhetoric of research. BMJ. 1995;310:985-7. [PMID: 0007728037] |
| 176 | Annals of Internal Medicine. Information for authors. Available at www.annals.org. Accessed 10 January 2001. |
| 177 | Docherty M, Smith R. The case for structuring the discussion of scientific papers. BMJ. 1999;318:1224-5. [PMID: 0010231230] |
| 178 | Purcell GP, Donovan SL, Davidoff F. Changes to manuscripts during the editorial process: characterizing the evolution of a clinical paper. JAMA. 1998;280:227-8. [PMID: 0009676663] |
| 179 | Kiviluoto T, Sirén J, Luukkonen P, Kivilaakso E. Randomised trial of laparoscopic versus open cholecystectomy for acute and gangrenous cholecystitis. Lancet. 1998;351:321-5. [PMID: 0009652612] |
| 180 | Silverstein FE, Faich G, Goldstein JL, et al. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. JAMA. 2000;284:1247-55. [PMID: 0010979111] |
| 181 | Campbell DT. Factors relevant to the validity of experiments in social settings. Psychology Bulletin. 1957;54:297-312. [PMID: 13465924] |
| 182 | Jüni P, Altman DG, Egger M. Assessing the quality of controlled clinical trials. In: Egger M, Davey Smith G, Altman DG, eds. Systematic reviews in health care: meta-analysis in context. London: BMJ Books; 2001. |
| 183 | Dans AL, Dans LF, Guyatt GH, Richardson S. Users' guides to the medical literature: XIV. How to decide on the applicability of clinical trial results to your patient. Evidence-Based Medicine Working Group. JAMA. 1998;279:545-9. [PMID: 0009480367] |
| 184 | Davey Smith G, Egger M. Who benefits from medical interventions? Treating low risk patients can be a high risk strategy. BMJ. 1994;308:72-4. [PMID: 0008298415] |
| 185 | McAlister FA. Applying the results of systematic reviews at the bedside. In: Egger M, Smith GD, Altman DG, eds. Systematic reviews in health care: meta-analysis in context. London: BMJ Books; 2001. |
| 186 | Laupacis A, Sackett DL, Roberts RS. An assessment of clinically useful measures of the consequences of treatment. N Engl J Med. 1988;318:1728-33. [PMID: 0003374545] |
| 187 | Altman DG. Confidence intervals for the number needed to treat. BMJ. 1998;317:1309-12. [PMID: 0009804726] |
| 188 | Fanaroff AA, Korones SB, Wright LL, et al. A controlled trial of intravenous immune globulin to reduce nosocomial infections in very-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. N Engl J Med. 1994;330:1107-13. [PMID: 0008133853] |
| 189 | ISIS-1 Collaborative Group. Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group. Lancet. 1986;2:57-66. [PMID: 0002873379] |
| 190 | Gøtzsche PC, Gjørup I, Bonnén H, Brahe NE, Becker U, Burcharth F. Somatostatin v placebo in bleeding oesophageal varices: randomised trial and meta-analysis. BMJ. 1995;310:1495-8. [PMID: 0007787594] |
| 191 | Cochrane Collaboration. The Cochrane Library. The Cochrane Library (Issue 1). 2000. Oxford: Update Software |
| 192 | Clarke M, Chalmers I. Discussion sections in reports of controlled trials published in general medical journals: islands in search of continents? JAMA. 1998;280:280-2. [PMID: 0009676682] |
| 193 | Goodman SN. Toward evidence-based medical statistics. 1: The P value fallacy. Ann Intern Med. 1999;130:995-1004. [PMID: 0010383371] |
| 194 | Gøtzsche PC. Reference bias in reports of drug trials. Br Med J (Clin Res Ed). 1987;295:654-6. [PMID: 0003117277] |
| 195 | Berlin JA, Begg C, Louis TA. An assessment of publication bias using a sample of published clinical trials. J Am Stat Assoc. 1989;84:381-92. |
| 196 | Guyatt GH, DiCenso A, Farewell V, Willan A, Griffith L. Randomized trials versus observational studies in adolescent pregnancy prevention. J Clin Epidemiol. 2000;53:167-74. [PMID: 0010729689] |
| 197 | Kunz R, Oxman AD. The unpredictability paradox: review of empirical comparisons of randomised and non-randomised clinical trials. BMJ. 1998;317:1185-90. [PMID: 0009794851] |
| 198 | Benson K, Hartz AJ. A comparison of observational studies and randomized, controlled trials. N Engl J Med. 2000;342:1878-86. [PMID: 0010861324] |
| 199 | Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med. 2000;342:1887-92. [PMID: 0010861325] |
| 200 | Collins R, MacMahon S. Reliable assessment of the effects of treatment on mortality and major morbidity, 1: clinical trials. Lancet. 2001;357:373-80. [PMID: 0011211013] |
| 201 | Moher D, Pham B, Jones A, et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet. 1998;352:609-13. [PMID: 0009746022] |
| 202 | Murray GD. Promoting good research practice. Stat Methods Med Res. 2000;9:17-24. [PMID: 0010826155] |
| 203 | Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet. 1999;354:1896-900. [PMID: 0010584742] |
| 204 | Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283:2008-12. [PMID: 0010789670] |
Page last edited: 02 April 2008
